DK1663243T3 - Farmaceutisk formulering omfattende et pyrimidin-a-on-derivat coatet med en enterisk polymer - Google Patents

Farmaceutisk formulering omfattende et pyrimidin-a-on-derivat coatet med en enterisk polymer

Info

Publication number
DK1663243T3
DK1663243T3 DK04764689T DK04764689T DK1663243T3 DK 1663243 T3 DK1663243 T3 DK 1663243T3 DK 04764689 T DK04764689 T DK 04764689T DK 04764689 T DK04764689 T DK 04764689T DK 1663243 T3 DK1663243 T3 DK 1663243T3
Authority
DK
Denmark
Prior art keywords
pyrimidine
pharmaceutical formulation
enteric polymer
derivative coated
derivative
Prior art date
Application number
DK04764689T
Other languages
English (en)
Inventor
Schie Dirk Marinus J Van
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1663243T3 publication Critical patent/DK1663243T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04764689T 2003-09-02 2004-08-31 Farmaceutisk formulering omfattende et pyrimidin-a-on-derivat coatet med en enterisk polymer DK1663243T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320522.6A GB0320522D0 (en) 2003-09-02 2003-09-02 Formulation
PCT/EP2004/009726 WO2005021002A1 (en) 2003-09-02 2004-08-31 Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer

Publications (1)

Publication Number Publication Date
DK1663243T3 true DK1663243T3 (da) 2009-05-04

Family

ID=28686767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04764689T DK1663243T3 (da) 2003-09-02 2004-08-31 Farmaceutisk formulering omfattende et pyrimidin-a-on-derivat coatet med en enterisk polymer

Country Status (30)

Country Link
US (2) US20060287346A1 (da)
EP (1) EP1663243B1 (da)
JP (1) JP4892346B2 (da)
KR (1) KR101115984B1 (da)
CN (2) CN102204891B (da)
AR (1) AR045547A1 (da)
AT (1) ATE422889T1 (da)
AU (1) AU2004268376B2 (da)
BR (1) BRPI0414038A (da)
CA (1) CA2537178C (da)
CY (1) CY1108953T1 (da)
DE (1) DE602004019547D1 (da)
DK (1) DK1663243T3 (da)
ES (1) ES2319124T3 (da)
GB (1) GB0320522D0 (da)
HR (1) HRP20090147T3 (da)
IL (1) IL173910A (da)
IS (1) IS2677B (da)
MA (1) MA28033A1 (da)
MX (1) MXPA06002436A (da)
MY (1) MY139165A (da)
NO (1) NO333744B1 (da)
NZ (1) NZ545453A (da)
PL (1) PL1663243T3 (da)
PT (1) PT1663243E (da)
RU (1) RU2359660C2 (da)
SI (1) SI1663243T1 (da)
TW (1) TWI343257B (da)
WO (1) WO2005021002A1 (da)
ZA (1) ZA200601599B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
CA2687079A1 (en) 2007-05-11 2008-11-20 The Trustees Of The University Of Pennsylvania Methods of treatment of skin ulcers
AU2007353454C8 (en) 2007-05-11 2014-04-24 Rowan University Methods of treatment and prevention of neurodegenerative diseases and disorders
MA33295B1 (fr) 2009-04-24 2012-05-02 Iceutica Pty Ltd Nouvelle formulation de diclofénac
JP2013545792A (ja) 2010-12-17 2013-12-26 グラクソ グループ リミテッド 眼疾患の処置および防止方法
WO2013082275A1 (en) 2011-11-30 2013-06-06 Trustees Of Boston College Inhibitors of phosphodiesterases 11 (pde11) and methods of use to elevate cortisol production
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
JP6625603B2 (ja) 2014-07-22 2019-12-25 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited 化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619570C1 (en) 1986-06-11 1987-10-29 Kneipp Werke Kneipp Mittel Zen Coated garlic tablet
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
TW209174B (da) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
JP2917799B2 (ja) * 1994-03-11 1999-07-12 田辺製薬株式会社 消化管内適所放出型製剤
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
JP3185206B2 (ja) * 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
ATE277605T1 (de) * 1996-06-06 2004-10-15 Bifodan As Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung
WO1998006385A1 (de) 1996-08-15 1998-02-19 Losan Pharma Gmbh Gut schluckbare orale arzneiform
US6296876B1 (en) * 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
CN1195500C (zh) * 1998-05-18 2005-04-06 武田药品工业株式会社 可口腔崩解的片剂
TR200101333T2 (tr) * 1998-11-12 2001-10-22 Smithkline Beecham P.L.C. Bir ensülin sensitizörü ve başka bir anti-diyabetik maddenin değiştirilmiş salımı için farmasötik terkip.
US6268385B1 (en) * 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
KR100781425B1 (ko) * 2000-02-16 2007-12-03 스미스클라인비이참피이엘시이 Ldl-pla2 억제제로서 피리미딘-4-온 유도체
AUPQ672800A0 (en) * 2000-04-06 2000-05-04 Natraherbal Pty Ltd Garlic supplement for deodoriser
ES2225624T3 (es) * 2000-06-28 2005-03-16 Smithkline Beecham Plc Procedimiento de molienda por via humeda.
ATE508725T1 (de) 2001-06-20 2011-05-15 Takeda Pharmaceutical Verfahren zur herstellung von tabletten
JP5138856B2 (ja) * 2001-06-20 2013-02-06 武田薬品工業株式会社 錠剤の製造方法
RU2203671C1 (ru) * 2002-03-25 2003-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Противовирусный лекарственный препарат для перорального применения
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation

Also Published As

Publication number Publication date
ATE422889T1 (de) 2009-03-15
IS2677B (is) 2010-09-15
MA28033A1 (fr) 2006-07-03
JP2007504195A (ja) 2007-03-01
AU2004268376B2 (en) 2010-04-22
TWI343257B (en) 2011-06-11
EP1663243B1 (en) 2009-02-18
PT1663243E (pt) 2009-04-27
SI1663243T1 (sl) 2009-06-30
KR101115984B1 (ko) 2012-03-13
IS8366A (is) 2006-03-20
IL173910A0 (en) 2006-07-05
WO2005021002A1 (en) 2005-03-10
CN102204891A (zh) 2011-10-05
AR045547A1 (es) 2005-11-02
CN1874778A (zh) 2006-12-06
NZ545453A (en) 2009-12-24
HRP20090147T3 (hr) 2009-04-30
US20060287346A1 (en) 2006-12-21
NO333744B1 (no) 2013-09-09
CY1108953T1 (el) 2014-07-02
HK1091734A1 (en) 2007-01-26
ES2319124T3 (es) 2009-05-04
AU2004268376A1 (en) 2005-03-10
RU2359660C2 (ru) 2009-06-27
TW200517113A (en) 2005-06-01
NO20061514L (no) 2006-04-03
PL1663243T3 (pl) 2009-07-31
MXPA06002436A (es) 2006-06-20
CN102204891B (zh) 2013-08-21
JP4892346B2 (ja) 2012-03-07
EP1663243A1 (en) 2006-06-07
CA2537178A1 (en) 2005-03-10
CA2537178C (en) 2013-03-19
GB0320522D0 (en) 2003-10-01
RU2006110546A (ru) 2006-08-10
BRPI0414038A (pt) 2006-10-24
US8772303B2 (en) 2014-07-08
IL173910A (en) 2010-11-30
CN1874778B (zh) 2011-06-22
MY139165A (en) 2009-08-28
KR20060118422A (ko) 2006-11-23
US20090306113A1 (en) 2009-12-10
ZA200601599B (en) 2007-05-30
DE602004019547D1 (de) 2009-04-02

Similar Documents

Publication Publication Date Title
CY2025003I1 (el) Λιποσωματα για τη χορηγηση φαρμακων
ATE380544T1 (de) Umhüllte feste darreichungsform
DK1545662T3 (da) Lægemiddelindgivelsessystem
DK2266650T3 (da) Lægemiddeldispenser
DE602005012107D1 (de) Pharmazeutische formulierungen mit einem antibioti
DE602004017700D1 (de) Transmukosen verabreichung
PT1501534E (pt) Formulacoes farmaceuticas
DK2609947T3 (da) Plasterlignende infusionsapparat
DE60316323D1 (de) Feste pharmazeutische formulierungen mit telmisartan
DE60311519D1 (de) Modulare beschichtungsvorrichtung
CY2013027PI2 (el) Νεα παραγωγα ινσουλινης
MA29039B1 (fr) Dibenzylamines et derives
ATE481402T1 (de) Pyrazolopyridin-derivate
NO20033815D0 (no) Farmasöytiske salter
MA28686B1 (fr) Derives de pyrrolopyridine
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
DK1663243T3 (da) Farmaceutisk formulering omfattende et pyrimidin-a-on-derivat coatet med en enterisk polymer
DE60209673D1 (de) Tablettenbeschichtungen
ATE546141T1 (de) Pharmazeutisches injektionspräparat
DK2918286T3 (da) En farmaceutisk formulering
DK1750765T3 (da) Farmaceutisk antimykobakteriesammensætning omfattende et antituberkulöst lægemiddel
IS7581A (is) Lyfjasamsetning
DE60212728D1 (de) Stabile pharmazeutische zusammensetzung mit erythropoietin
DE10393889D2 (de) Medikament-Dosimeter-Kombipackung
CY1127305T1 (el) Λιποσωματα για τη χορηγηση φαρμακων